Test Price
2,800 AED✅ Home Collection Available
FYCO1 Gene Genetic Test (Autosomal Recessive Congenital Cataract Type 2) in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Verified Specialist: Consultant Medical Genetics oversight ensures molecular accuracy.
Test Overview & Methodology
The FYCO1 gene NGS test decodes the complete coding sequence of the FYCO1 gene to detect pathogenic variants responsible for autosomal recessive congenital cataract type 2, a severe pediatric eye disorder. This analysis uses next‑generation sequencing (NGS) to capture all exons and flanking intronic regions, enabling detection of novel and deep intronic variants beyond targeted Sanger sequencing.
| Our Test | Sanger Sequencing (Alternative) |
|---|---|
| NGS Full-Gene Analysis | Targeted Mutations Only |
| Detects novel & deep intronic variants | Limited to known hot‑spots |
| 3–4 Weeks TAT | 4–6 Weeks TAT |
| Clinical sensitivity >99% | ~85% (misses CNVs) |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403): "A positive FYCO1 mutation confirms the genetic aetiology of congenital cataract in your child, but the clinical outcome also depends on timely surgical intervention and multidisciplinary follow‑up. Genetic counselling helps you understand the autosomal recessive inheritance pattern, enabling accurate carrier risk estimation for family planning. Always correlate molecular findings with a comprehensive ophthalmologic and paediatric evaluation."
Advisory Notice
Do not discontinue prescribed medication without consulting your doctor. This test does not replace acute ophthalmologic care.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria (Do not proceed with home collection if):
- Patient is unable to provide informed consent; minors require legal guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Known current febrile illness or systemic infection that may affect sample quality (defer collection).
- Inability to obtain a proper venous blood sample (severe dehydration, shock).
Emergency Red Flags – Seek immediate hospital care if:
- Sudden vision loss or severe eye pain in the tested child.
- Red, swollen eyelid with pus‑like discharge (possible glaucoma/infection).
- Abnormal eye movements or acute strabismus onset.
Patient FAQ & Clinical Guidance
1. What exactly does the FYCO1 gene NGS test diagnose?
This test identifies pathogenic DNA variants in the entire FYCO1 gene that cause autosomal recessive congenital cataract type 2, confirming the genetic root of the child’s cataract and enabling carrier testing for family members.
2. How is the sample collected?
A trained DHA‑licensed phlebotomist performs a gentle venous blood draw (or a simple finger‑prick for a dried blood spot FTA card) at your home, causing only mild, momentary discomfort.
3. When will I receive my results, and how are they explained?
Your report is ready within 3 to 4 weeks, delivered through a secure online portal, followed by a pre‑scheduled telephone consultation with a clinical geneticist who will explain the findings in plain language.
UAE Regulatory & Data Privacy Adherence
All genetic testing procedures at DNA Labs UAE comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for handling of sensitive health information. Data storage and transmission follow Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. Our DHA‑licensed facility ensures the highest standards of confidentiality and ethical practice.
Clinical & Logistical Metadata
| Test Name | FYCO1 Gene Genetic Test (Autosomal Recessive Congenital Cataract Type 2) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Exon + Flanking Intronic Regions |
| ICD-10-CM Code | Q12.0 |
| LOINC Code | 55233-1 |
| DHA Facility License & Laboratory Address | Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians